CA-125 and Severity of Pre-Eclampsia

NCT02704676 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2016-03-18

No results posted yet for this study

Summary

The Aim of this study is to determine the relationship between serum concentrations of cancer antigen-125 (CA-125) and pre-eclampsia severity.

Conditions

  • Pre-Eclampsia

Interventions

OTHER

marker(CA-125)

measuring CA-125 in pregnant women (normal,mild and sever pre-eclampsia)

Sponsors & Collaborators

  • Ain Shams Maternity Hospital

    lead OTHER

Principal Investigators

  • Hassan Tawfek, Pofessor · ain-shams university , cairo

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2016-07-31
Completion
2016-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02704676 on ClinicalTrials.gov